Prenetics Global Limited Q2 FY2026 Earnings Call

· Earnings call transcript and AI-powered summary

Prenetics (IM8) Q2 2026 Earnings Summary

Financial Highlights (Q2 2026)

  • Total Revenue: $46.5 million (+29% QoQ; 3.9x YoY). Met guidance of $46-48 million.
  • IM8 Revenue: $45 million (+33% QoQ). Met guidance of $44-46 million. Gross margin: 65% (+3 pts YoY).
  • Gross Profit: $30.2 million (65% margin).
  • Contribution Profit: $21.4 million (46% of sales; +16 pts YoY).
  • Adjusted EBITDA: -$19 million (driven by doubled marketing spend vs. Q1).
  • Net Loss: $9 million ($0.52/share; -45% YoY from $0.94/share loss).
  • Key Metrics: 118,000 new customers acquired in Q2 (+98% QoQ); CAC flat to slightly down (-1%).

July 2026 Preliminary Results (Strongest Month)

  • Revenue: $20.9-21.4 million (4.3x YoY; ~$251 million annualized run rate).
  • New Customers: 47,373 (record cohort) at CAC of $239 (-21% vs. Q2 average).
  • Gross Margin: 64%; Contribution margin: 49%.
  • Adjusted EBITDA: -$2.4 million (-11% margin).
  • Adjusted Free Cash Flow: Turned positive for the first time (includes General Catalyst facility).

Guidance & Outlook

Continue Reading

Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.

Upgrade to Professional
Operator: Actual results may differ materially. Please refer to the company's filings with the SEC. Certain figures for July are preliminary and unaudited. The full Q2 2026 shareholder letter and this investor presentation were published this morning and are available at ir.prenetics.com. With that, it is my pleasure to hand the call over to Prenetics CEO, Danny. Sheng Wu Yeung: Thank you, Shannon. Good morning, everyone. Before anything else, thank you so much for being here. This is actually the first live earnings video webcast we've done in our company's history. And from the numbers looking -- from numbers that are joining right now, it may be the largest group of our shareholders ever gathered in one place. So whether you manage a fund, hold a single share or simply here because you drink the sachet every morning, welcome. This is for you. And here's why we're doing it this way. Our shareholders range from global institutions to people who found IM8 as customers and became shareholders. And we believe every one of them deserves the same depth of information at the same moment. This moment, we've opened the books to everyone at once. We can do that for a simple reason. We now have 20 months of data, every cohort, every month, every market measured end-to-end. Enough history that numbers no longer need my adjectives. And I will say this plainly, I do not know of another company publicly traded or private that has shown its business in this level of detail in which we are

Continue Reading

Unlock the full earnings call transcript with speaker labels and formatted dialogue.

Upgrade to Professional